The store will not work correctly when cookies are disabled.
1-(Butyl)-3-((1H-benzo[d]imidazol-2-yl)methyl)imidazolium chloride
ID: ALA3759516
PubChem CID: 10402002
Max Phase: Preclinical
Molecular Formula: C15H19ClN4
Molecular Weight: 255.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCn1cc[n+](Cc2nc3ccccc3[nH]2)c1.[Cl-]
Standard InChI: InChI=1S/C15H19N4.ClH/c1-2-3-8-18-9-10-19(12-18)11-15-16-13-6-4-5-7-14(13)17-15;/h4-7,9-10,12H,2-3,8,11H2,1H3,(H,16,17);1H/q+1;/p-1
Standard InChI Key: PYEVGZUHKBRJDJ-UHFFFAOYSA-M
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
14.2654 1.0982 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.2995 1.5073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1799 2.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2796 3.7097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5896 2.9790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9505 3.6058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1763 2.7399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5395 3.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5197 2.6754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
2 6 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
8 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
10 16 2 0
11 13 2 0
7 8 1 0
3 7 1 0
6 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M CHG 2 1 -1 3 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.34 | Molecular Weight (Monoisotopic): 255.1604 | AlogP: 2.50 | #Rotatable Bonds: 5 |
Polar Surface Area: 37.49 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.78 | CX Basic pKa: 3.95 | CX LogP: -1.06 | CX LogD: -1.06 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.70 | Np Likeness Score: -1.19 |
References
1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855] [10.1016/j.bmc.2016.02.012] |